Cargando…

Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors

Migraine affects over 40 million Americans and is the world’s second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headache subspecialty practices, healthcare system interventions should focus on primary care. Though ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Langenbahn, Donna, Matsuzawa, Yuka, Lee, Yuen Shan Christine, Fraser, Felicia, Penzien, Donald B., Simon, Naomi M, Lipton, Richard B., Minen, Mia T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849617/
https://www.ncbi.nlm.nih.gov/pubmed/33527189
http://dx.doi.org/10.1007/s11606-020-06539-x
_version_ 1783645342898585600
author Langenbahn, Donna
Matsuzawa, Yuka
Lee, Yuen Shan Christine
Fraser, Felicia
Penzien, Donald B.
Simon, Naomi M
Lipton, Richard B.
Minen, Mia T.
author_facet Langenbahn, Donna
Matsuzawa, Yuka
Lee, Yuen Shan Christine
Fraser, Felicia
Penzien, Donald B.
Simon, Naomi M
Lipton, Richard B.
Minen, Mia T.
author_sort Langenbahn, Donna
collection PubMed
description Migraine affects over 40 million Americans and is the world’s second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headache subspecialty practices, healthcare system interventions should focus on primary care. Though there is grade A evidence for behavioral treatment (e.g., biofeedback, cognitive behavioral therapy (CBT), and relaxation techniques) for migraine, these treatments are underutilized. Behavioral treatments may be a valuable alternative to opioids, which remain widely used for migraine, despite the US opioid epidemic and guidelines that recommend against them. Identifying and removing barriers to the use of headache behavioral therapy could help reduce the disability as well as the personal and social costs of migraine. These techniques will have their greatest impact if offered in primary care settings to the lower socioeconomic status groups at greatest risk for migraine. We review the societal and cultural challenges that impose barriers to optimal use of non-pharmacological treatment services. These barriers include insufficient knowledge of migraine/headache behavioral treatments and insufficient availability of clinicians trained in non-pharmacological treatment delivery; limited access in underserved communities; financial burden; and stigma associated with both headache and mental health diagnoses and treatment. For each barrier, we discuss potential approaches to minimizing its effect and thus enhancing non-pharmacological treatment utilization. Case Example A 25-year-old graduate student with a prior history of headaches in college is attending school in the evenings while working a full-time job. Now, his headaches have significant nausea and photophobia. They are twice weekly and are disabling enough that he is unable to complete homework assignments. He does not understand why the headaches occur on Saturdays when he pushes through all week to get through his examinations that take place on Friday evenings. He tried two different migraine preventive medications, but neither led to the 50% reduction in headache days his doctor had hoped for. His doctor had suggested cognitive behavioral therapy (CBT) before initiating the medications, but he had been too busy to attend the appointments, and the challenges in finding an in-network provider proved difficult. Now with the worsening headaches, he opted for the CBT and by the fifth week had already noted improvements in his headache frequency and intensity.
format Online
Article
Text
id pubmed-7849617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78496172021-02-02 Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors Langenbahn, Donna Matsuzawa, Yuka Lee, Yuen Shan Christine Fraser, Felicia Penzien, Donald B. Simon, Naomi M Lipton, Richard B. Minen, Mia T. J Gen Intern Med Review Paper Migraine affects over 40 million Americans and is the world’s second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headache subspecialty practices, healthcare system interventions should focus on primary care. Though there is grade A evidence for behavioral treatment (e.g., biofeedback, cognitive behavioral therapy (CBT), and relaxation techniques) for migraine, these treatments are underutilized. Behavioral treatments may be a valuable alternative to opioids, which remain widely used for migraine, despite the US opioid epidemic and guidelines that recommend against them. Identifying and removing barriers to the use of headache behavioral therapy could help reduce the disability as well as the personal and social costs of migraine. These techniques will have their greatest impact if offered in primary care settings to the lower socioeconomic status groups at greatest risk for migraine. We review the societal and cultural challenges that impose barriers to optimal use of non-pharmacological treatment services. These barriers include insufficient knowledge of migraine/headache behavioral treatments and insufficient availability of clinicians trained in non-pharmacological treatment delivery; limited access in underserved communities; financial burden; and stigma associated with both headache and mental health diagnoses and treatment. For each barrier, we discuss potential approaches to minimizing its effect and thus enhancing non-pharmacological treatment utilization. Case Example A 25-year-old graduate student with a prior history of headaches in college is attending school in the evenings while working a full-time job. Now, his headaches have significant nausea and photophobia. They are twice weekly and are disabling enough that he is unable to complete homework assignments. He does not understand why the headaches occur on Saturdays when he pushes through all week to get through his examinations that take place on Friday evenings. He tried two different migraine preventive medications, but neither led to the 50% reduction in headache days his doctor had hoped for. His doctor had suggested cognitive behavioral therapy (CBT) before initiating the medications, but he had been too busy to attend the appointments, and the challenges in finding an in-network provider proved difficult. Now with the worsening headaches, he opted for the CBT and by the fifth week had already noted improvements in his headache frequency and intensity. Springer International Publishing 2021-02-01 2021-10 /pmc/articles/PMC7849617/ /pubmed/33527189 http://dx.doi.org/10.1007/s11606-020-06539-x Text en © Society of General Internal Medicine 2021
spellingShingle Review Paper
Langenbahn, Donna
Matsuzawa, Yuka
Lee, Yuen Shan Christine
Fraser, Felicia
Penzien, Donald B.
Simon, Naomi M
Lipton, Richard B.
Minen, Mia T.
Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title_full Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title_fullStr Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title_full_unstemmed Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title_short Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors
title_sort underuse of behavioral treatments for headache: a narrative review examining societal and cultural factors
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849617/
https://www.ncbi.nlm.nih.gov/pubmed/33527189
http://dx.doi.org/10.1007/s11606-020-06539-x
work_keys_str_mv AT langenbahndonna underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT matsuzawayuka underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT leeyuenshanchristine underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT fraserfelicia underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT penziendonaldb underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT simonnaomim underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT liptonrichardb underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors
AT minenmiat underuseofbehavioraltreatmentsforheadacheanarrativereviewexaminingsocietalandculturalfactors